Publications by authors named "Julia Carvalhinho Carlos DE Souza"
Article Synopsis
- Deep Brain Stimulation (DBS) has been FDA-approved since 2003 and is recommended for treating dystonia after other treatments, like botulinum toxin, fail.
- A study analyzed the impact of DBS on botulinum toxin dosages in 23 dystonic patients, showing a significant reduction in medication use after surgery.
- Pre-surgery, patients received a median of 800 units of botulinum toxin, which decreased to 700 units post-surgery, indicating a 12.5% reduction in dosage after DBS treatment.
Background: More than one-third of COVID-19 patients present neurological symptoms ranging from anosmia to stroke and encephalopathy. Furthermore, pre-existing neurological conditions may require special treatment and may be associated with worse outcomes. Notwithstanding, the role of neurologists in COVID-19 is probably underrecognized.
View Article and Find Full Text PDF